Analyst Research Report Snapshot

Title:

Hikma Pharmaceuticals PLC

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

23 Jan 2013

Pages:

38

Type:

AcrobatPDF

Companies referenced:

HIK.L

Available for Immediate Download
Summary:

Hikma Pharmaceuticals PLC - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs - Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Hikma Pharmaceuticals (Hikma) is engaged in the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. The company is focused on therapeutic areas, including anesthetics, anti-histamines, anti-infectives, cardiovascular, diabetes, central nervous system, gastroenterology and metabolism, muscoloskeletal system, dermatology, genitourinary system, hormones, oncology, respiratory system transplantation, vitamins and supplements. The company primarily operates in the Middle East and North Africa (MENA) region, the US and Europe. It is headquartered in London, the UK, and employs around 5,400 people. The company recorded revenues of $730.9 million in the fiscal year ended December 2010, an increase of 14.8% over 2009. The company's operating profit was $135.1 million in fiscal 2010, an increase of 25.9% over 2009. Its net profit was $98.8 million in fiscal 2010, an increase of 27.2% over 2009. Reasons to Purchase: - Gain understanding of Hikma Pharmaceuticals PLC the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Hikma Pharmaceuticals PLC your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.